Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
---|
08/19/2004 | WO2004069814A1 Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
08/19/2004 | WO2004069774A2 Synthesis of 13c-labelled estrogen analogues |
08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
08/19/2004 | WO2004048335A3 Mandelic acid derivatives |
08/19/2004 | WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors |
08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
08/19/2004 | US20040162431 Permanent surface modifiers |
08/19/2004 | US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
08/19/2004 | US20040162247 Administering quercetin or at least one derivative for ameliorating the symptoms associated with osteoporosis |
08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
08/19/2004 | CA2515116A1 Amino-1,3,5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
08/18/2004 | EP1446398A1 Manufacture of alpha- tocopherol |
08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
08/18/2004 | EP1230234B1 Naphthopyrans annelated in c5-c6 with an indene-or dihydronaphthalene-type ring and compositions and matrices containing them |
08/18/2004 | CN1521164A Pyran isoflavone molluscacide synthesizing method and formulation |
08/18/2004 | CN1520719A Snow lotus flavone active ingredient production method by cultivating acaleph snow lotus trichome |
08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
08/18/2004 | CN1162421C New process for extracting high purity puerarin by pure water method |
08/17/2004 | US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
08/12/2004 | WO2004052873A9 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
08/12/2004 | WO2004046162A3 Non-steroidal fxr agonists |
08/12/2004 | WO2004045557A3 Novel lapachone compounds and methods of use thereof |
08/12/2004 | WO2004026857A3 Methods of purifying cannabinoids from plant material |
08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
08/12/2004 | WO2002076395A3 Agents and methods for treatment of cancer |
08/12/2004 | US20040158083 Method of extracting and isolating minor components from vegetable oil |
08/12/2004 | US20040158082 Process for the preparation of isoflavones |
08/12/2004 | US20040157862 estrogen agonist/antagonist is (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol; A kit for use by a consumer to treat osteoarthritis, the kit comprising: estrogen agonist/antagonist; COX-2 inhibitor |
08/12/2004 | US20040157857 Substituted chroman derivatives |
08/12/2004 | US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
08/12/2004 | US20040157739 Used for the control of a range of harmful weeds |
08/12/2004 | US20040157738 Novel oxygen containing fused cyclic derivatives and herbicidal, desiccant and defoliate compositions containing them |
08/12/2004 | US20040156925 Plant proanthocyanidin extract effective at inhibiting utility |
08/11/2004 | EP1445324A1 Process for producing optically active chroman derivative and intermediate |
08/11/2004 | EP1445257A1 Chromene compound |
08/11/2004 | EP1444177A1 Extraction of phenolic antioxidants |
08/11/2004 | EP1360182B1 4-aminobenzopyran derivatives |
08/11/2004 | CN1520406A Substituted benzopyran derivatives aganst arrhythmia |
08/10/2004 | US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative. |
08/10/2004 | CA2306008C Composition for and method of reducing low density lipoprotein cholesterol concentration |
08/05/2004 | WO2004065539A2 Androgen receptor antagonists |
08/05/2004 | WO2004064830A1 Processed fat compositions for preventing and improving lifestyle-related diseases |
08/05/2004 | WO2004064722A2 Process for the production of oxandrolone |
08/05/2004 | WO2004021969A3 Non-nucleoside reverse transcriptase inhibitors |
08/05/2004 | WO2003086288A3 Bicyclic amides |
08/05/2004 | WO2003020860A3 Methods for treating deodorizer distillate |
08/05/2004 | US20040152763 Cardiovascular disorders |
08/05/2004 | US20040152762 Oxidation resistance; from hesperidin using Aspergillus fermentation |
08/05/2004 | US20040152761 Dimeric isoflavones |
08/05/2004 | CA2511491A1 Androgen receptor antagonists |
08/04/2004 | EP1443044A1 Process for the preparation of fungicide iodo-chromone derivatives |
08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
08/04/2004 | CN1518536A Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
08/04/2004 | CN1517343A Extraction method of huckleberry anthocyanidin |
08/04/2004 | CN1517086A Medical use of poly hydroxy flavone derivatives |
08/04/2004 | CN1160299C Hairyleaf peudoyingzhaosu C as one compound with antineoplastic activite compound |
08/03/2004 | US6770764 Diagnosis of bacteria infections |
08/03/2004 | US6770671 Angiogenic inhibitors; anticarcinogenic agents, antitumor agents; rheumatoid arthritis, diabetic retinopathy treatment |
08/03/2004 | US6770630 Plants and insecticidal compositions comprising the naringenin derivatives as active components. |
08/03/2004 | US6770385 Fluorescent bis-coumarins for organic light-emitting devices |
07/29/2004 | WO2004063182A1 PROCESS FOR THE MANUFACTURE OF α-TOCOPHERYL ACETATE |
07/29/2004 | WO2004062601A2 Antibacterial agents |
07/29/2004 | WO2004050011A3 High enantiomeric purity dexanabinol for pharmaceutical copositions |
07/29/2004 | WO2004024093A3 Device and method for treating restenosis |
07/29/2004 | WO2004022703A3 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
07/29/2004 | WO2004012682A3 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
07/29/2004 | WO2003096982A3 Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
07/29/2004 | US20040147728 Method for increasing hydrophilicity of fluorescent label compounds |
07/29/2004 | US20040147594 Compositions and products containing R-equol, and methods for their making |
07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
07/29/2004 | US20040147035 Diaminorhodamine derivative |
07/29/2004 | CA2851462A1 Antibacterial agents |
07/29/2004 | CA2512582A1 Antibacterial agents |
07/28/2004 | EP1441011A1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye |
07/28/2004 | EP1441010A1 Fluorinated xanthene derivatives |
07/28/2004 | EP1440688A1 Peroxisome proliferator activated receptor ligands and process for producing the same |
07/28/2004 | CN1516872A Optical data carrier that contains triazacyanine dye as light-absorbing compound in information layer |
07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
07/28/2004 | CN1515565A Sarcandra flavones coumarins total extract, its medicine composition and application |
07/28/2004 | CN1515524A Method for extracting isoflavone, flavones and lactone from armenica sibirica leaf by adoptnig solvent method |
07/28/2004 | CN1515523A Method for extracting isoflavone, flavones and lactone from armeniaca sibirica leaf by adopting resin method |
07/28/2004 | CN1159308C Method for separating high purity catechin compound from tea extration |
07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
07/28/2004 | CN1159284C Aminomethylation of tocopherols |
07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
07/27/2004 | US6768008 For therapy |
07/27/2004 | US6767916 Chalcone coumarins |
07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
07/22/2004 | US20040143126 converting cannabidiol to Delta 8 or Delta 9-tetrahydrocannabinol by mixing the diol with a catalyst and solvent and allowing the mixture to separate, removing the organic phase; and eluting the tetrahydrocannabinol from the organic phase |
07/22/2004 | US20040143123 zirconium complexes of bis(o-hydroxybenzylamines); further reaction of dicarbonyls such as methyl (2S)-5-chloro-2,3-dihydro-2-hydroxy-1-oxo-1H-indene-2-carboxylate with protected hydrazine and N-(XC(O))-N-methoxycarbonyl-p-(trifluoromethyl)aniline |
07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
07/22/2004 | US20040142928 particularly against herpes viruses |
07/21/2004 | EP1438337A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
07/21/2004 | EP1438303A2 Flavonoid compounds and their pharmaceutical uses |
07/21/2004 | EP1438288A1 Substituted thioacetamides |
07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
07/21/2004 | CN1515002A Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers |
07/21/2004 | CN1514845A Oxime ester photoinitiatros having combined structure |